|
Macedonian Journal of Medical Sciences. 2011 Dec
15;
4(4):408-410.
http://dx.doi.org/10.3889/MJMS.1957-5773.2011.0194
Case Report
Fatal Sepsis Due to Stenotrophomonas Maltophilia in Stem Cell Recipient – Case Report
Zlate Stojanoski
University Clinic of Hematology, Faculty of Medicine, University “Ss
Cyril and Methodius”, Skopje, Republic of Macedonia
Background: Infections are frequent cause of further morbidity and
mortality in stem cells recipients. Infection-related mortality is mainly
due to severe bacterial sepsis, pneumonia and fungal infections.
Case Report: We report a 60 years old patient with AML. In the
complete remission he is received high-dose chemotherapy followed by
autologous peripheral blood stem cell transplantation. The patient was
treated in sterile room, conditioned with HEPA filters. Antibiotic
prophylaxis regimen consisted Ciprofloxacin 1.0 gr/day, Itraconazol 400
mg/day, Acyclovir 1500 mg/day, and Immunoglobulins IV 0.1 mg/kg once per
week. From day +5 patient became febrile (Ne<0.5 x 103/mL). First line
antibiotic regimen consisted third-generation anti-pseudomonal
cephalosporine and amynoglicoside during a 72 h, but with no response. As a
second line antibiotic therapy was introduced Vancomicyn 2.0 gr/day. On day
+10 from blood culture and urine culture was isolated Stenotrophomonas
maltophillia with in vitro succeptibilities only to Ciprofloxacin (+3).
Co-trimoxasole and again Ciprofloxacin in maximal doses was administered,
but patient deteriorate, and in sepsis with signes of endotoxic shock he die
on day +15.
Conclusion: Despite use of broad-spectrum antibiotics as prophylaxis,
Gram-negative bacteria are still potentially fatal for immunocompromised
patients. Microbiological monitoring on local microflora is mandatory for
all transplant centers and intensive care units.
...................
Citation: Stojanoski Z. Fatal Sepsis Due to Stenotrophomonas
Maltophilia in Stem Cell Recipient – Case Report. Maced J Med Sci. 2011 Dec
15; 4(4):408-410. http://dx.doi.org/10.3889/MJMS.1957-5773.2011.0194.
Key words: infective; complications; stem; cell; transplantation.
Correspondence: Dr. Zlate Stojanoski. University Clinic of
Hematology, Faculty of Medicine, University “Ss Cyril and Methodius”,
Skopje, Republic of Macedonia. E-mail: stojanoskiza@mt.net.mk
Received: 30-Jun-2011; Revised: 29-Sep-2011; Accepted: 01-Oct-2011; Online
first: 13-Oct-2011
Copyright: © 2011 Stojanoski Z. This is an open access article
distributed under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.
Competing Interests: The author have declared that no competing
interests exist.
|
<
Previous
| Next Article >
Table of contents
This Article
(free)
Abstract
Full text (html)
Full text (pdf)
Full text OnlineFirst (pdf)
Citations
- DOAJ
- Index Copernicus
- Socol@r
Google Scholar
- Stojanoski Z
PubMed
- Stojanoski Z
|